P2X7 Receptor Promotes Mouse Mammary Cancer Cell Invasiveness and Tumour Progression, and Is a Target for Anticancer
Lucie Brisson1, Stéphanie Chadet2, Osbaldo Lopez-Charcas2
1Inserm UMR1069-Nutrition, Growth and Cancer, University of Tours, 37032 Tours, France.
Abstract:
The P2X7 receptor is an ATP-gated cation channel with a still ambiguous role in cancer progression, proposed to be either pro- or anti-cancerous, depending on the cancer or cell type in the tumour. Its role in mammary cancer progression is not yet defined. Here, we show that P2X7 receptor is functional in highly aggressive mammary cancer cells, and induces a change in cell morphology with fast F-actin reorganization and formation of filopodia, and promotes cancer cell invasiveness through both 2- and 3-dimensional extracellular matrices in vitro. Furthermore, P2X7 receptor sustains Cdc42 activity and the acquisition of a mesenchymal phenotype. In an immunocompetent mouse mammary cancer model, we reveal that the expression of P2X7 receptor in cancer cells, but not in the host mice, promotes tumour growth and metastasis development, which were reduced by treatment with specific P2X7 antagonists. Our results demonstrate that P2X7 receptor drives mammary tumour progression and represents a pertinent target for mammary cancer treatment.
Insights
The P2X7 receptor drives aggressive mammary cancer progression by promoting cell invasiveness and metastasis. Blocking this receptor with antagonists effectively reduced tumor growth in mouse models, highlighting its therapeutic potential.
Area of Science:
- Oncology
- Cell Biology
- Immunology
Background:
- The P2X7 receptor's role in cancer progression is controversial, with potential pro- or anti-cancer effects.
- Its specific function in mammary cancer remains undefined.
Purpose of the Study:
- To investigate the role of the P2X7 receptor in mammary cancer progression.
- To determine if P2X7 receptor is a viable therapeutic target for mammary cancer.
Main Methods:
- Functional assays in aggressive mammary cancer cells.
- In vitro invasion assays using 2D and 3D extracellular matrices.
- In vivo studies using an immunocompetent mouse mammary cancer model.
- Treatment with specific P2X7 receptor antagonists.
Main Results:
- P2X7 receptor is functional in aggressive mammary cancer cells, inducing morphological changes and promoting invasiveness.
- P2X7 receptor sustains Cdc42 activity and mesenchymal phenotype acquisition.
- In vivo, P2X7 receptor expression in cancer cells promoted tumor growth and metastasis, which were reduced by antagonists.
Conclusions:
- The P2X7 receptor actively drives mammary tumor progression and metastasis.
- Targeting the P2X7 receptor with antagonists shows promise for mammary cancer treatment.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation


